Characteristics | PDAC n (%) (N = 23 640) | PNEN n (%) (N = 596) |
---|---|---|
Age at diagnosis, years | ||
25–29 | 11 (0.05) | <5 |
30–39 | 129 (0.55) | 25 (4.19) |
40–49 | 666 (2.82) | 84 (14.09) |
50–59 | 2325 (9.84) | 118 (19.80) |
60–69 | 5176 (21.89) | 177 (29.70) |
70–79 | 7717 (32.64) | 135 (22.65) |
≥80 | 7616 (32.22) | 54 (9.06) |
Route to diagnosis | ||
Death certificate | 85 (0.36) | <5 |
Emergency presentation | 5542 (23.44) | 78 (13.09) |
GP referral | 2442 (10.33) | 147 (24.66) |
Inpatient elective | 364 (1.54) | 23 (3.86) |
Other outpatient pathway | 1125 (4.76) | 112 (18.79) |
2-week-wait | 1887 (7.98) | 57 (9.56) |
Not recorded | 12 195 (51.59) | 178 (29.87) |
Stage at diagnosis (TNM) | ||
Stage I | 274 (1.16) | 62 (10.40) |
Stage II | 769 (3.25) | 53 (8.89) |
Stage III | 593 (2.51) | 27 (4.53) |
Stage IV | 4016 (16.99) | 161 (27.01) |
Not recorded | 17 988 (76.09) | 293 (49.16) |
Grade at diagnosis | ||
Well differentiated | 303 (1.28) | 230 (38.59) |
Moderately differentiated | 1683 (7.12) | 58 (9.73) |
Poorly differentiated | 1702 (7.20) | 61 (10.23) |
Undifferentiated | 49 (0.21) | <5 (NA) |
Not recorded | 19 903 (84.19) | 246 (41.28) |
Type of tumour | ||
Functional NEN | NA | 16 (2.68) |
Non-functional NEN | NA | 271 (45.47) |
Neuroendocrine carcinoma | NA | 274 (45.97) |
Mixed adenocarcinoma/NEN | NA | 8 (1.34) |
Other/NOS | NA | 23 (3.86) |
PDAC | 23 640 (100) | NA |
Treatment | ||
Surgery | ||
No | 17 026 (72.02) | 220 (36.91) |
Yes | 6614 (27.98) | 376 (63.09) |
Chemotherapy | ||
No | 19 402 (82.07) | 430 (72.15) |
Yes | 4238 (17.93) | 166 (27.85) |
Radiotherapy | ||
No | 23 000 (97.29) | 557 (93.46) |
Yes | 640 (2.71) | 39 (6.54) |
Hormone therapy | ||
No | 23 574 (99.72) | 550 (92.28) |
Yes | 66 (0.28) | 46 (7.72) |
Other treatment | ||
No | 19 030 (80.50) | 458 (76.85) |
Yes | 4610 (19.50) | 138 (23.15) |
↵a Rows with counts <5 have been suppressed. NA = not applicable. NEN = neuroendocrine neoplasm. NOS = not otherwise specified. PDAC = pancreatic ductal adenocarcinoma. PNEN = pancreatic neuroendocrine neoplasm. TNM = TNM Classification of Malignant Tumours.